Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.

Deporte-Fety, R; Simon, N; Fumoleau, P; Campone, M; Kerbrat, P; Bonneterre, J; Fargeot, P; Urien, S.

Cancer Chemother Pharmacol ; 53(3): 233-8, 2004 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-14634791

2.

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

Nabholtz, J M; Gelmon, K; Bontenbal, M; Spielmann, M; Catimel, G; Conte, P; Klaassen, U; Namer, M; Bonneterre, J; Fumoleau, P; Winograd, B.

J Clin Oncol ; 14(6): 1858-67, 1996 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-8656254

3.

Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients.

Alexandre, J; Bleuzen, P; Bonneterre, J; Sutherland, W; Misset, J L; Guastalla, J; Viens, P; Faivre, S; Chahine, A; Spielman, M; Bensmaïne, A; Marty, M; Mahjoubi, M; Cvitkovic, E.

J Clin Oncol ; 18(3): 562-73, 2000 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-10653871

4.

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Rougier, P; Bugat, R; Douillard, J Y; Culine, S; Suc, E; Brunet, P; Becouarn, Y; Ychou, M; Marty, M; Extra, J M; Bonneterre, J; Adenis, A; Seitz, J F; Ganem, G; Namer, M; Conroy, T; Negrier, S; Merrouche, Y; Burki, F; Mousseau, M; Herait, P; Mahjoubi, M.

J Clin Oncol ; 15(1): 251-60, 1997 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-8996150

5.

Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.

Urien, S; Fumoleau, P; Campone, M; Kerbrat, P; Bonneterre, J; Fargeot, P; Deporte-Fety, R.

Cancer Chemother Pharmacol ; 52(2): 99-107, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12768319

6.

Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer. The French Epirubicin Study Group.

Bonneterre, J; Mercier, M.

Cancer Treat Rev ; 19 Suppl B: 21-30, 1993 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-8481930

7.

Effectiveness of cold cap in the prevention of docetaxel-induced alopecia.

Lemenager, M; Lecomte, S; Bonneterre, M E; Bessa, E; Dauba, J; Bonneterre, J.

Eur J Cancer ; 33(2): 297-300, 1997 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-9135504

8.

Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer.

Adenis, A; Pion, J M; Fumoleau, P; Pouillart, P; Marty, M; Giroux, B; Bonneterre, J.

Cancer Chemother Pharmacol ; 35(6): 527-8, 1995.

Artículo en Inglés | MEDLINE | ID: mdl-7882462

9.

Ineffectiveness of sequential high dose methotrexate and 5-fluorouracil combined with epirubicin (FEMTX regimen) as a salvage therapy in advanced colorectal cancers and other gastrointestinal tumors.

Adenis, A; Leriche, N; Pion, J M; Vanlemmens, L; Bonneterre, J.

Anticancer Res ; 16(4A): 2063-7, 1996.

Artículo en Inglés | MEDLINE | ID: mdl-8712743

10.

UFT/leucovorin plus vinorelbine combination for advanced breast cancer.

Fumoleau, P; Déporte, R; Kerbrat, P; Bonneterre, J; Fargeot, P.

Oncology (Williston Park) ; 14(10 Suppl 9): 50-5, 2000 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-11098494

11.

[A medico-economic evaluation of second line chemotherapy in metastatic breast cancer: comparison between docetaxel, paclitaxel, and vinorelbine]. / Evaluation médico-économique de la chimiothérapie de 2e ligne dans le cancer du sein métastatique: comparaison du docétaxel, du paclitaxel et de la vinorelbine.

Launois, R J; Reboul-Marty, J M; Bonneterre, J.

Bull Cancer ; 84(7): 709-21, 1997 Jul.

Artículo en Francés | MEDLINE | ID: mdl-9339197

12.

Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.

Kerbrat, P; Roché, H; Bonneterre, J; Veyret, C; Lortholary, A; Monnier, A; Fumoleau, P; Fargeot, P; Namer, M; Chollet, P; Goudier, M-J; Audhuy, B; Simon, H; Montcuquet, P; Eymard, J-C; Walter, S; Clavère, P; Guastalla, J-P.

Br J Cancer ; 96(11): 1633-8, 2007 Jun 04.

Artículo en Inglés | MEDLINE | ID: mdl-17505516

13.

Is adjuvant chemotherapy useful in lobular breast cancer patients?

Liem, X; Baranzelli, M C; Penel, N; Giard, S; Bonneterre, J.

Ann Oncol ; 22(11): 2532-2533, 2011 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-21700733

14.

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.

Fumoleau, P; Roché, H; Kerbrat, P; Bonneterre, J; Romestaing, P; Fargeot, P; Namer, M; Monnier, A; Montcuquet, P; Goudier, M-J; Luporsi, E.

Ann Oncol ; 17(1): 85-92, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16251204

15.

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials.

Namer, M; Fargeot, P; Roché, H; Campone, M; Kerbrat, P; Romestaing, P; Monnier, A; Luporsi, E; Montcuquet, P; Bonneterre, J.

Ann Oncol ; 17(1): 65-73, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16361531

16.

Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial.

Roché, H; Kerbrat, P; Bonneterre, J; Fargeot, P; Fumoleau, P; Monnier, A; Clavère, P; Goudier, M-J; Chollet, P; Guastalla, J-P; Serin, D.

Ann Oncol ; 17(8): 1221-7, 2006 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-16731539

17.

Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 versus FEC 100 (FASG05 study).

Bonneterre, J; Bercez, C; Bonneterre, M-E; Lenne, X; Dervaux, B.

Ann Oncol ; 16(6): 915-22, 2005 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-15894546

18.

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.

Campone, M; Roché, H; Kerbrat, P; Bonneterre, J; Romestaing, P; Fargeot, P; Namer, M; Monnier, A; Montcuquet, P; Goudier, M-J; Fumoleau, P.

Ann Oncol ; 16(8): 1343-51, 2005 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15905306

19.

Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy.

Peyrat, J P; Révillion, F; Bonneterre, J.

Br J Cancer ; 77(10): 1669-71, 1998 May.

Artículo en Inglés | MEDLINE | ID: mdl-9635846

20.

Phase I and pharmacokinetic study of weekly oral therapy with vinorelbine in patients with advanced breast cancer (ABC).

Bonneterre, J; Chevalier, B; Focan, C; Mauriac, L; Piccart, M.

Ann Oncol ; 12(12): 1683-91, 2001 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-11843245

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: